WANG; Shixia

Patent Applications and Registrations

Patent applications and USPTO patent grants for WANG; Shixia.The latest application filed is for "use of mitoxantrone liposome for treating non-hodgkin's lymphoma".

Company Profile

3.10.17

WANG; Shixia - Shijiazhuang Hebei
Wang; Shixia - Northborough MA

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Use Of Mitoxantrone Liposome For Treating Non-hodgkin's Lymphoma App 20210267915 - LI; Chunlei ; et al.	2021-09-02
Compositions And Methods To Treat Aids App 20210138062 - Lu; Shan ; et al.	2021-05-13
Compositions and methods to treat AIDS Grant 10,869,921 - Lu , et al. December 22, 2	2020-12-22
Purified Therapeutic Nanoparticles And Preparation Methods Thereof App 20200060982 - Li; Chunlei ; et al.	2020-02-27
Purified therapeutic nanoparticles and preparation methods thereof Grant 10,500,165 - Li , et al. Dec	2019-12-10
Compositions And Methods To Treat Aids App 20190160165 - Lu; Shan ; et al.	2019-05-30
Compositions and methods to treat aids Grant 10,124,060 - Lu , et al. November 13, 2	2018-11-13
Compositions And Methods To Treat Aids App 20170258892 - Lu; Shan ; et al.	2017-09-14
Compositions and methods to treat AIDS Grant 9,675,687 - Lu , et al. June 13, 2	2017-06-13
Immunogenic polypeptides comprising a modified loop peptide presenting the HIV-1 GP120 3074 mAb epitope and scaffold proteins containing said peptide Grant 9,534,020 - Cardozo , et al. January 3, 2	2017-01-03
Compositions And Methods To Treat Aids App 20160015802 - Lu; Shan ; et al.	2016-01-21
Purified Therapeutic Nanoparticles And Preparation Methods Thereof App 20160000726 - Li; Chunlei ; et al.	2016-01-07
Immunogenic Polypeptides Having An Immunogenic Scaffold Protein And A Loop Peptide, Presenting A 3074- Or 2219/2557- Monoclonal Antibody-targeted Epitope, Which Is Present In The Hiv Gp120 Protein App 20130287804 - Cardozo; Timothy ; et al.	2013-10-31
Polyvalent, Primary Hiv-1 Glycoprotein Dna Vaccines And Vaccination Methods App 20110171258 - Lu; Shan ; et al.	2011-07-14
Polyvalent, primary HIV-1 glycoprotein DNA vaccines and vaccination methods Grant 7,901,690 - Lu , et al. March 8, 2	2011-03-08
Recombinant HIV-1 gp120 immunogen with three different V3 loops from viruses of different clades Grant 7,847,085 - Zolla-Pazner , et al. December 7, 2	2010-12-07
Poxvirus methods and compositions Grant 7,807,180 - Lu , et al. October 5, 2	2010-10-05
Influenza Nucleic Acids, Polypeptides, And Uses Thereof App 20090291472 - Lu; Shan ; et al.	2009-11-26
Influenza nucleic acids, polypeptides, and uses thereof Grant 7,566,454 - Lu , et al. July 28, 2	2009-07-28
Poxvirus Methods And Compositions App 20090053256 - Lu; Shan ; et al.	2009-02-26
Recombinant HIV-1 gp120 Immunogen with Three Different V3 Loops from Viruses of Different Clades App 20080095791 - Zolla-Pazner; Susan ; et al.	2008-04-24
Sars Nucleic Acids, Proteins, Vaccines, and Uses Thereof App 20070270361 - Lu; Shan ; et al.	2007-11-22
Influenza nucleic acids, polypeptides, and uses thereof App 20060217338 - Lu; Shan ; et al.	2006-09-28
Methods and compositions for solid tumor treatment App 20040266713 - Lu, Shan ; et al.	2004-12-30
Polyvalent, primary HIV-1 glycoprotein DNA vaccines and vaccination methods App 20040191269 - Lu, Shan ; et al.	2004-09-30

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.